What is the recommended dosage frequency of guaifenesin for a patient with chest congestion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guaifenesin Dosing Frequency

For adults and children 12 years and older, take guaifenesin every 4 hours, not exceeding 6 doses in 24 hours. 1

Dosing by Age Group

Adults and Children ≥12 Years

  • Immediate-release formulation: 200-400 mg every 4 hours (maximum 6 doses/24 hours) 1, 2
  • Extended-release formulation: 1200 mg (two 600 mg tablets) every 12 hours 3, 4

Children 6 to <12 Years

  • Immediate-release: 100-200 mg (1-2 teaspoonfuls of liquid) every 4 hours 1
  • Maximum 6 doses in 24 hours 1

Children 2 to <6 Years

  • Immediate-release: 50-100 mg (½ to 1 teaspoonful) every 4 hours 1
  • Maximum 6 doses in 24 hours 1

Children <2 Years

  • Consult a physician before use 1

Formulation Considerations

Extended-release guaifenesin offers the advantage of 12-hour dosing compared to 4-hour dosing required for immediate-release formulations. 2, 3 The extended-release bi-layer tablet formulation maintains therapeutic plasma concentrations over 12 hours and is bioequivalent to corresponding immediate-release doses given every 4 hours 3. At steady state, 1200 mg extended-release every 12 hours provides equivalent exposure to 400 mg immediate-release every 4 hours 3.

Important Dosing Caveats

  • Multiple daily doses are necessary to maintain 24-hour therapeutic effect with immediate-release formulations due to guaifenesin's short half-life 2
  • Extended-release formulations can be taken with or without food, though Tmax is delayed in the fed state 3
  • The 4-hour dosing interval for immediate-release products allows flexible dose titration (200-400 mg range) to optimize therapeutic plasma concentrations 2
  • Treatment duration in clinical studies typically ranged from 7 days for acute upper respiratory tract infections 4, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.